Clinical Study
Treatment of Rhinitis Sicca Anterior with Ectoine Containing Nasal Spray
Table 4
Patients’ assessments of secondary symptom scores at days 3, 6, 9, and 12 following treatment start of study 2.
| | Symptoms | d3 | d6 | d9 | d12 | value (d3 versus d12) |
| | Nose bleeding | 0.70 ± 1.60 | 0.73 ± 1.72 | 0.50 ± 1.01 | 0.17 ± 0.59 | 0.0019 | | Pharyngitis | 1.07 ± 2.26 | 0.67 ± 1.63 | 0.57 ± 1.19 | 0.60 ± 1.00 | 0.719 | | Exudate viscosity | 2.67 ± 2.38 | 2.50 ± 2.64 | 2.10 ± 2.23 | 1.67 ± 2.19 | 0.027 | | Rhinorrhea | 2.57 ± 1.99 | 2.00 ± 1.72 | 1.90 ± 1.83 | 1.57 ± 1.45 | 0.025 | | Cacosmia | 0.90 ± 2.26 | 0.70 ± 1.82 | 0.33 ± 0.99 | 0.30 ± 0.99 | 0.005 |
|
|
